Cases & Deals

  • Home
  • Practices
  • Financière Arbevel forms Arbevel Life Sciences Crossover II fund

Share

Financière Arbevel forms Arbevel Life Sciences Crossover II fund

December 2024

Client(s) Financière Arbevel

Jones Day advised Financière Arbevel in connection with the creation of "Arbevel Life Sciences Crossover II," a private equity fund focusing on European biotech small and mid cap companies.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.